How to Properly Diagnose and Treat Immune-Related Adverse Events During Immunotherapy in Patients with Cancer: Discussion Between Specialists
Immune checkpoint inhibitors and other immune-based cancer therapies have profoundly transformed the treatment of solid and hematological malignancies, leading to durable responses and significant survival benefits in a growing number of patients [...].
Authors
- Angioletta Lasagna (ORCID: https://orcid.org/0000-0002-9611-1164)
- P. Sacchi
Institutions
- Policlinico San Matteo Fondazione (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-05
- DOI
- https://doi.org/10.3390/cancers18030523
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00